• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

塔斯马尼亚岛甲状腺癌发病率和谱在从碘充足向碘缺乏转变期间(1978 - 1998年)的变化

The changing incidence and spectrum of thyroid carcinoma in Tasmania (1978-1998) during a transition from iodine sufficiency to iodine deficiency.

作者信息

Burgess J R, Dwyer T, McArdle K, Tucker P, Shugg D

机构信息

Department of Diabetes and Endocrine Services, Royal Hobart Hospital, Australia.

出版信息

J Clin Endocrinol Metab. 2000 Apr;85(4):1513-7. doi: 10.1210/jcem.85.4.6554.

DOI:10.1210/jcem.85.4.6554
PMID:10770190
Abstract

Exposure to ionizing radiation, changing levels of iodine nutrition, and increased pathologic diagnosis of clinically unimportant thyroid neoplasia have all been proposed as explanations for a worldwide rise in the incidence of thyroid carcinoma (TC) over the past 6 decades. Tasmania is geographically an area of endemic iodine deficiency. In this report, we describe the spectrum of TC in a population averaging 450,000 persons during a 21-yr period that spans the communities transition from iodine sufficiency to iodine deficiency after discontinuation of universal iodine prophylaxis in the mid 1980s. The Tasmanian Cancer Register was used to ascertain all cases of TC diagnosed in Tasmania between 1978 and 1998. Histopathological and demographic data were reviewed. A total of 289 cases of TC were identified. Papillary TC (PTC), follicular TC, medullary TC, and other species accounted for 62%, 23%, 4%, and 11% of cases, respectively. The age standardized incidence rate for total TC increased from 2.45 to 5.33 per 100,000 for females and 0.75 to 1.76 per 100,000 for males between 1978 and 1984 and 1992 and 1998, respectively. A rise in the incidence of PTC by 4.5-fold (P < 0.05) in females and 2.1-fold in males (not significant) was the dominant change over this period. In parallel, the proportion of follicular TC relative to PTC fell from 0.35 to 0.17 during these years (P < 0.05). The rise in PTC incidence was, in part, due to an increase in the occurrence of tumors 1cm or less in diameter. Nonetheless, a 3-fold rise in incidence of larger lesions was also observed during the study period. Forty-three (24%) PTC cases had multifocal disease, 17 (40%) of whom had bilateral tumors. Familial (autosomal dominant) PTC was identified in nine (5%) total PTC cases. Prior studies have linked iodine prophylaxis to a rise in the proportion of differentiated TC, particularly PTC. Our data suggest a complex relationship between iodine nutrition and thyroid tumorigenesis. Factors such as a long latency between changes in iodine nutrition and thyroid tumorigenesis, a dose threshold for the effect of iodine nutrition on thyroid tumorigenesis, and an interaction between iodine nutrition and thyroidal sensitivity to ionizing radiation may all play a role.

摘要

过去60年里,电离辐射暴露、碘营养水平变化以及临床上不重要的甲状腺肿瘤病理诊断增加,都被认为是全球甲状腺癌(TC)发病率上升的原因。塔斯马尼亚在地理上是碘缺乏流行地区。在本报告中,我们描述了在一个平均有45万人的人群中,21年间TC的发病情况,这一时期跨越了20世纪80年代中期全民碘预防措施停止后,社区从碘充足到碘缺乏的转变。利用塔斯马尼亚癌症登记处确定了1978年至1998年间在塔斯马尼亚诊断出的所有TC病例,并对组织病理学和人口统计学数据进行了回顾。共识别出289例TC病例。乳头状TC(PTC)、滤泡状TC、髓样TC和其他类型分别占病例的62%、23%、4%和11%。1978年至1984年以及1992年至1998年间,女性TC的年龄标准化发病率从每10万人2.45例增至5.33例,男性从每10万人0.75例增至1.76例。在此期间,主要变化是女性PTC发病率上升了4.5倍(P<),男性上升了2.1倍(无统计学意义)。同时,这些年里滤泡状TC相对于PTC的比例从0.35降至0.17(P<)。PTC发病率上升部分归因于直径1厘米及以下肿瘤发生率的增加。尽管如此,在研究期间,较大病变的发病率也上升了3倍。43例(24%)PTC病例有多灶性病变,其中17例(40%)有双侧肿瘤。在所有PTC病例中,9例(5%)被确定为家族性(常染色体显性)PTC。先前的研究将碘预防措施与分化型TC尤其是PTC比例的上升联系起来。我们的数据表明碘营养与甲状腺肿瘤发生之间存在复杂关系。碘营养变化与甲状腺肿瘤发生之间的长时间潜伏期、碘营养对甲状腺肿瘤发生影响的剂量阈值以及碘营养与甲状腺对电离辐射敏感性之间的相互作用等因素可能都起到了作用。

相似文献

1
The changing incidence and spectrum of thyroid carcinoma in Tasmania (1978-1998) during a transition from iodine sufficiency to iodine deficiency.塔斯马尼亚岛甲状腺癌发病率和谱在从碘充足向碘缺乏转变期间(1978 - 1998年)的变化
J Clin Endocrinol Metab. 2000 Apr;85(4):1513-7. doi: 10.1210/jcem.85.4.6554.
2
Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982-1997).澳大利亚甲状腺癌的时间趋势:甲状腺乳头状癌发病率上升(1982 - 1997年)
Thyroid. 2002 Feb;12(2):141-9. doi: 10.1089/105072502753522374.
3
Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine-needle aspirate cytology.甲状腺乳头状癌的发病趋势及其与甲状腺手术和甲状腺细针穿刺细胞学检查的相关性。
Thyroid. 2006 Jan;16(1):47-53. doi: 10.1089/thy.2006.16.47.
4
Papillary thyroid cancer incidence in the volcanic area of Sicily.西西里岛火山地区的甲状腺乳头状癌发病率。
J Natl Cancer Inst. 2009 Nov 18;101(22):1575-83. doi: 10.1093/jnci/djp354. Epub 2009 Nov 5.
5
A prospective study of thyroid nodular disease in children and adolescents in western Poland from 1996 to 2000 and the incidence of thyroid carcinoma relative to iodine deficiency and the Chernobyl disaster.1996年至2000年波兰西部儿童和青少年甲状腺结节疾病的前瞻性研究以及相对于碘缺乏和切尔诺贝利灾难的甲状腺癌发病率。
Pediatr Blood Cancer. 2004 Jan;42(1):84-92. doi: 10.1002/pbc.10421.
6
Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria: 1984-2001. Histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: population-based age-stratified analysis on thyroid carcinoma incidence.奥地利克恩顿州甲状腺癌的描述性流行病学:1984 - 2001年。自1990年以来食盐普遍加碘情况下734例病例的组织病理学特征及肿瘤分类:基于人群的甲状腺癌发病率年龄分层分析。
Thyroid. 2004 Apr;14(4):277-86. doi: 10.1089/105072504323030933.
7
Increased incidence of papillary thyroid cancer detection among thyroidectomies in Greece between 1991 and 2006.希腊 1991 年至 2006 年间甲状腺切除术患者甲状腺乳头状癌检出率增高。
Anticancer Res. 2009 Dec;29(12):5163-9.
8
[Correlation between endemic iodine deficiency and radiation-induced thyroid cancer in children and adolescents].[儿童和青少年地方性碘缺乏与辐射诱发甲状腺癌之间的相关性]
Vopr Onkol. 2002;48(3):311-7.
9
Influence of iodine deficiency and iodine prophylaxis on thyroid cancer histotypes and incidence in endemic goiter area.碘缺乏与碘预防对地方性甲状腺肿地区甲状腺癌组织类型及发病率的影响。
J Endocrinol Invest. 2003;26(2 Suppl):71-6.
10
Changing trends of incidence and prognosis of thyroid carcinoma in lower Franconia, Germany, from 1981-1995.1981年至1995年德国下弗兰肯地区甲状腺癌发病率和预后的变化趋势
Thyroid. 2004 Feb;14(2):141-7. doi: 10.1089/105072504322880382.

引用本文的文献

1
Trace elements and the thyroid.微量元素与甲状腺。
Front Endocrinol (Lausanne). 2022 Oct 24;13:904889. doi: 10.3389/fendo.2022.904889. eCollection 2022.
2
Epidemiology of Thyroid Cancer.甲状腺癌流行病学
Cancer Epidemiol Biomarkers Prev. 2022 Jul 1;31(7):1284-1297. doi: 10.1158/1055-9965.EPI-21-1440.
3
Global burden of thyroid cancer and its attributable risk factors in 204 countries and territories from 1990 to 2019.2019 年全球 204 个国家和地区甲状腺癌的发病负担及其归因危险因素。
Thorac Cancer. 2021 Sep;12(18):2494-2503. doi: 10.1111/1759-7714.14099. Epub 2021 Aug 5.
4
Changing incidence and projections of thyroid cancer in mainland China, 1983-2032: evidence from Cancer Incidence in Five Continents.中国内地甲状腺癌的发病率变化及预测,1983-2032 年:来自《五大洲癌症发病率》的证据。
Cancer Causes Control. 2021 Oct;32(10):1095-1105. doi: 10.1007/s10552-021-01458-6. Epub 2021 Jun 21.
5
Genetics of Familial Non-Medullary Thyroid Carcinoma (FNMTC).家族性非髓样甲状腺癌(FNMTC)的遗传学
Cancers (Basel). 2021 Apr 30;13(9):2178. doi: 10.3390/cancers13092178.
6
Thyroid carcinoma in children, adolescents, and young adults in Brazil: A report from 11 population-based cancer registries.巴西儿童、青少年和青年甲状腺癌:来自 11 个基于人群的癌症登记处的报告。
PLoS One. 2020 May 1;15(5):e0232416. doi: 10.1371/journal.pone.0232416. eCollection 2020.
7
Geographic influences in the global rise of thyroid cancer.甲状腺癌在全球范围内的上升与地理因素有关。
Nat Rev Endocrinol. 2020 Jan;16(1):17-29. doi: 10.1038/s41574-019-0263-x. Epub 2019 Oct 15.
8
Growing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis.近年来甲状腺癌发病率不断上升:过度诊断的潜在因素。
Head Neck. 2018 Apr;40(4):855-866. doi: 10.1002/hed.25029. Epub 2017 Dec 5.
9
Association between Hashimoto's Thyroiditis and Thyroid Cancer in 64,628 Patients.64628例患者中桥本甲状腺炎与甲状腺癌的关联
Front Oncol. 2017 Apr 10;7:53. doi: 10.3389/fonc.2017.00053. eCollection 2017.
10
Iodine intake as a risk factor for BRAF mutations in papillary thyroid cancer patients from an iodine-replete area.碘摄入量是富含碘地区甲状腺癌患者 BRAF 突变的一个风险因素。
Eur J Nutr. 2018 Mar;57(2):809-815. doi: 10.1007/s00394-016-1370-2. Epub 2017 Mar 3.